“Inpharma”: the “Patent on the Shelf” mechanism will be applied only when a foreign pharmaceutical company leaves the Russian market
The State Duma explained to foreign pharmaceutical companies under what conditions the “Patent on the Shelf” mechanism will operate, allowing...